Environmental sustainability in pharmaceutical manufacturing

In this article, Brian Peutherer of Sterling Pharma Solutions discusses some of the considerations API manufacturers take into account when assessing the sustainability of facilities and processes, and highlights some of the commitments and investments that Sterling has made to its site in Dudley, UK.
 
silverstream.tv

Latest news

22nd October 2021

GTP Bioways invests €12M in two GMP biopharmaceutical production units

18th October 2021
Nanoform convenes EGM to elect Jeanne Thoma as board member
18th October 2021
New product is intended to support biologic drugs with high viscosity formulations*, complex design space requirements and support the delivery of medications for chronic diseases
18th October 2021
Accelerate development of GMP-grade production enzymes essential for manufacturing mRNA-based biopharmaceuticals
6th October 2021
The Royal Swedish Academy of Sciences has decided to award the 2021 Nobel Prize in Chemistry to Benjamin List and David W.C. MacMillan “for the development of asymmetric organocatalysis.”
6th October 2021
SYNER-G PHARMA CONSULTING ANNOUNCES NEW BRAND AND WEBSITE; COMPANY TO BE KNOWN AS SYNER-G BIOPHARMA GROUP
6th October 2021
Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan
5th October 2021
CrestOptics introduces DeepSIM super resolution confocal microscope module
5th October 2021
Gisèle Deblandre Joins Cellbox Solutions as CSO
5th October 2021
Brenntag extends distribution agreement with Evonik: Dynasylan product range now available in 19 European countries
5th October 2021
Mogrify Strengthens Executive Leadership Team with the Appointment of Louise Modis as Chief Scientific Officer
5th October 2021
CN Bio expands service offering to support oncology drug discovery
1st October 2021
Owlstone Medical closes $58 million financing round
1st October 2021
Optibrium releases 3D ligand-based design module for drug discovery software
1st October 2021
Metrion Biosciences expands into new headquarters at Granta Park
1st October 2021
GammaDelta Therapeutics initiates Phase 1 trial of AML treatment
1st October 2021
Cellbox Solutions establishes US subsidiary
1st October 2021
Boehringer Ingelheim acquires Abexxa Biologics
1st October 2021
BIOVECTRA enhances manufacturing capacity with ABEC microbial fermentation technology
1st October 2021
AstraZeneca to invest $360 million in advanced manufacturing facility in Ireland

This week’s featured articles

Cellular orchestration solutions support cell and gene therapy supply chain

Dr Fiona Withey, CEO and Co-Founder, explains how UK-headquartered TrakCel identified its market niche and how its integrated technologies support the management of the international autologous and allogeneic cell, gene and immunotherapy value chain.

Life Sciences

Gyros Protein Technologies and Cygnus Technologies

Through their recently expanded collaboration, Gyros Protein Technologies and Cygnus Technologies are now able to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform for the detection of host cell impurities from HEK 293 cells used in vaccine and viral vector manufacturing for cell and gene therapies and vaccines

Pharmaceuticals

Minaris Regenerative Medicine invests in new manufacturing facilities

European and Asian cell and gene therapy manufacturing capacity expansions complement new US commercial facility

Life Sciences

No More Weakest Links: Examining the Shifting Focus of the Pharmaceutical Supply Chain

The Covid-19 pandemic has exposed and affected all links across the pharmaceutical supply chain. For many decades the industry has relied heavily on a lean principle of inventory, however, this strategy reduced flexibility and the ability of our industry supply chains to absorb even minor disruptions.

Life Sciences

Bone Therapeutics: diversified portfolio of cell and biologic therapies

Bone Therapeutics is focused on the development of innovative products to address high unmet medical needs in orthopedics and other diseases and has a diversified portfolio of cell and biologic therapies at different stages ranging from preclinical programmes in immunomodulation to mid- to late-stage clinical development for orthopedic conditions.

Pharmaceuticals

Life Sciences Knowledge Hub

Stay up to date with industry news

Get the latest digital magazine and up to date news delivered right to your inbox.

Inside this issue
  • Drug Discovery
  • Biologics/Contract Manufacture
  • Continuous Manufacturing
  • Cell and Gene Therapy
  • Drug Delivery
  • Vaccines
  • Analytical Science
  • Pharma: Global Business
  • Sustainability/Environment
  • Supply Chain/Distribution


Previous Issues

Spotlight on Life Sciences

Find out more

Ethical Innovation Awards 2021

The Chemicals Knowledge Awards in partnership with CPhI North America celebrate ethical innovation throughout the Pharmaceutical industry. A lot of companies in the pharmaceutical industry are showing remarkable social responsibility, all the way from their drug manufacturing, through development and to delivery. At Chemicals Knowledge, we believe that those projects deserve to be recognised, celebrated and shared. That’s why Chemicals Knowledge is partnering with CPhI North America for the launch of the Ethical Innovation Awards - to bring together the best of the best in the pharmaceutical industry.

Find out more

Partnered with top industry events and organisations



logo
logo
logo
logo
logo